---
document_datetime: 2024-07-11 11:40:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/truqap-epar-all-authorised-presentations_en.pdf
document_name: truqap-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6195728
conversion_datetime: 2025-12-23 04:51:05.103919
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                    | (Invented) name   | Strength      | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging                 | Pack size             |
|-----------------------------------|-------------------|---------------|---------------------------------------|---------------------------|-------------------------------------|-----------------------|
| EU/1/24/1820/001 EU/1/24/1820/002 | Truqap Truqap     | 160 mg 200 mg | Film-coated tablet Film-coated tablet | Oral use Oral use         | blister (alu/alu) blister (alu/alu) | 64 tablets 64 tablets |